Ovesco Endoscopy AG

Ovesco Endoscopy AG The Ovesco Endoscopy AG is a medical device company operating in the fields of flexible endoscopy.

What if most perforations never had to reach the OR? 🤔 A real-world study from a tertiary center in Paris answered tha...
11/09/2026

What if most perforations never had to reach the OR? 🤔

A real-world study from a tertiary center in Paris answered that question – with 8 years of data.

👉 Before OTSC®: 62.5% of perforations required surgery.
👉 After OTSC®: Only 12.5%.

That's not a marginal improvement. That's a fundamental shift in how perforations are managed.

For patients, this means:
▪️No general anesthesia
▪️No abdominal incision
▪️Shorter recovery
▪️Fewer complications

For your department, this means:
▪️ Lower costs through faster patient discharge
▪️Reduced OR burden
▪️Effective resource management

Evidence-based implementation. Real-world impact.

More information on OTSC®neo – the best-studied closure device:
🔗 https://hubs.la/Q04xcJ3C0

Source: Khater S, et al. Endosc Int Open 2017; 5(5): E389-E394. DOI: 10.1055/s-0043-104862

FTRD®neo – Peak performance in clip applicationThe next generation of full-thickness resection builds on 10+ years of pr...
09/09/2026

FTRD®neo – Peak performance in clip application

The next generation of full-thickness resection builds on 10+ years of proven FTRD® evidence — now taken to a new level of reliability and usability.

📊 The data behind it:
✔️ Technical success up to 90%
✔️ R0 resection rates up to 82% (94% for subepithelial lesions)
✔️ Low complication rates
✔️ ~60% lower cost per R0 resection vs. surgery

Backed by 140+ publications and 10 meta-analyses, FTRD®neo confirms EFTR as a reliable alternative to surgery — across colon, re**um, stomach, duodenum and appendix.

👉 Explore the full clinical evidence in our new Clinical Bulletin: https://hubs.la/Q04wTNHb0

Precise tissue approximation changes everything. Here's the proof. 🎯 The OTSC® Twin Grasper® was designed for one critic...
03/09/2026

Precise tissue approximation changes everything. Here's the proof. 🎯

The OTSC® Twin Grasper® was designed for one critical purpose: to grasp both perforation edges simultaneously and achieve true serosa-to-serosa approximation before clip deployment.

Why does this matter?
- Reduces the risk of inadvertently grasping adjacent organs
- Ensures full-thickness closure from the first attempt
- Mean closure time: only 5 minutes 44 seconds

The prospective multicenter evidence (Voermans et http://al., 11 European centers):
✅ 92% technical success (33/36)
✅ 89% clinical success (32/36)
✅ 0% contrast leakage on post-procedural imaging
✅ Only 8% required primary surgical intervention

More information on OTSC®neo – the best-studied closure device:
🔗 https://hubs.la/Q04ws_BF0
🔗 https://hubs.la/Q04wsZnh0

Source: Voermans RP, et al. Clin Gastroenterol Hepatol 2012; 10(6): 603-608. DOI:10.1016/j.cgh.2012.02.005

27/08/2026

Wir sehen uns auf der Viszeralmedizin 2026 in Hamburg! 🤗

Wir freuen uns, vom 16. bis 19. September 2026 in Hamburg für Sie vor Ort zu sein! Besuchen Sie unser Team am Stand B.06.

In diesem Jahr erwartet Sie ein besonderes Highlight:

👉 Erleben Sie FTRD®neo am Stand! Lernen Sie unser neuestes Produkt erstmals auf einem Kongress aus nächster Nähe kennen.

Sie möchten einen ersten exklusiven Einblick in den TandemLoop erhalten?

👉 Dann besuchen Sie unseren Vortrag „Zwei Schlingen, ein Ziel: Der TandemLoop für die Fremdkörperentfernung“ im Rahmen des DEGEA-Workshops und freuen Sie sich auf eine kompakte Einführung mit anschließendem Hands-On.

🗓️ 19. September 2026
⏰ 9:00 – 12:30 Uhr

Wir freuen uns darauf, Sie begrüßen zu dürfen! 😊

Live Webinar | First-Line Hemostasis – What Does the Evidence Say?Bleeding management is one of the most critical challe...
25/08/2026

Live Webinar | First-Line Hemostasis – What Does the Evidence Say?

Bleeding management is one of the most critical challenges in gastrointestinal endoscopy, and the evidence is evolving fast.

Join us on for a one-hour session with leading endoscopists:

🎤 Dr. Milan Bassan (Australia) 🎤 Prof. James Lau (Hong Kong)

Together, they'll cover the following topics:
👉 Real-world clinical insights from experienced practitioners
👉 Current clinical evidence on first-line hemostasis strategies and RCT data
👉 Guideline-based approaches – what the data really tells us
👉 Practical takeaways you can apply in your daily clinical practice

📅 Thursday, 10th of September 2026

🕗 8 AM CEST | 2 PM SGT | 4 PM AEST

Don't miss out – register now for free and secure your spot:
https://hubs.ly/Q04v8Wr10

We look forward to seeing you there!

*This post is intended exclusively for healthcare professionals. Please refer to the instructions for use and note country-specific approvals and indications.

21/08/2026

Not all closures are created equal. Here's why it matters. 💡

Mucosal defects (Sydney type I & II) can often be managed with conventional through-the-scope clips. But when you're facing true full-thickness wall defects – type III & IV perforations, fistulae, or anastomotic leaks – you need a device that was specifically engineered for that challenge.

The OTSC®neo System delivers full-thickness, serosa-to-serosa closure with a compression force that holds. Not a superficial approximation – a true seal.

The evidence for clinical success?
✅ 85.3% in acute perforations (468 patients)¹
✅ 72.6% in anastomotic leaks (391 patients)¹
✅ 70.3 – 94% in fistulae¹ ²

When the defect goes deep, your closure device needs to match.

More information on OTSC®neo– the best-studied closure device:
🔗 https://hubs.la/Q04tw27q0

Sources:
1 Bartell N, et al. World J Gastroenterol 2020; 26(24): 3495-3516. DOI: 10.3748/wjg.v26.i24.3495
2 Vella Baldacchino A, et al. Endoscopy 2024; 54(S02): S157. DOI: 10.1055/s-0044-1783412

18/08/2026

Our new building is becoming a reality, floor by floor! 😊

In our latest construction update, the walls on the first floor are complete and the concrete slabs for both the warehouse and first floor have now been poured.

With progress moving at full speed, the structural shell will be completed very soon.

Join Marian and our site manager from F.K. Systembau for an exciting behind-the-scenes look at the construction site and watch the new building take shape!

Watch the full video on YouTube and make sure to follow us so you never miss an update on our new building.
👉 https://hubs.la/Q04t90Mk0

Think you know the FTRD®neo System inside out? Put your knowledge to the test! 😊Swipe through the images below and tackl...
13/08/2026

Think you know the FTRD®neo System inside out? Put your knowledge to the test! 😊

Swipe through the images below and tackle our quiz questions on the key facts and applications of the FTRD®neo System.

Check the answers and find out if you’re an FTRD®neo quiz champion! 😎

Head over to our website and discover all the exciting product enhancements featured in the quiz!
https://hubs.la/Q04sT-5F0

*Please note that the new FTRD®neo System may not yet be available in your country. This content is intended exclusively for healthcare professionals. Please refer to the instructions for use and country-specific approvals and indications.

🕑 2 AM: Emergency GI bleeding. à 93.1 % clinical success¹🕗 8 AM: Iatrogenic perforation during colonoscopy. à 85.3% clin...
10/08/2026

🕑 2 AM: Emergency GI bleeding. à 93.1 % clinical success¹

🕗 8 AM: Iatrogenic perforation during colonoscopy. à 85.3% clinical success²

🕑 2 PM: Switch from EVT to OTSC for remaining small leakage à Patient can be discharged 13 days earlier than with EVT alone³

🕓 4 PM: Chronic fistula with tissue preparation. → Up to 94% clinical success.⁴

The OTSC®neo System is the only closure device your department needs to cover a broad spectrum – from acute emergencies to planned interventions.
Different indications – same confidence.

More information on OTSC®neo – the best-studied closure device:
🔗 https://hubs.la/Q04smlL00

*This post is intended exclusively for healthcare professionals. Please refer to the instructions for use and note country-specific approvals and indications.

Sources:
1 Alali, A. A., et al. 2024; Saudi J Gastroenterol. 30(4), 200–209. DOI: 10.4103/sjg.sjg_86_24
2 Bartell N, et al. World J Gastroenterol 2020; 26(24): 3495-3516. DOI: 10.3748/wjg.v26.i24.3495
3 Kollmann L, et al. Endosc Int Open 2024; 12(9): E1023-E1028. DOI: 10.1055/a-2359-0857
4 Vella Baldacchino A, et al. Endoscopy 2024; 54(S02): S157. DOI: 10.1055/s-0044-1783412

Adresse

Friedrich-Miescher-Straße 9
Tübingen
72076

Öffnungszeiten

Montag 08:00 - 17:00
Dienstag 08:00 - 17:00
Mittwoch 08:00 - 17:00
Donnerstag 08:00 - 17:00
Freitag 08:00 - 17:00

Telefon

+49707196528160

Webseite

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Ovesco Endoscopy AG erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Verknüpfungen

Teilen

Kategorie